Michael York - Feb 27, 2022 Form 4 Insider Report for Metacrine, Inc. (MTCR)

Role
Chief Business Officer
Signature
/s/ Michael York
Stock symbol
MTCR
Transactions as of
Feb 27, 2022
Transactions value $
$0
Form type
4
Date filed
3/1/2022, 03:55 PM
Previous filing
Feb 24, 2022
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTCR Common Stock Award $0 +211K $0.00 211K Feb 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MTCR Stock option (right to buy) Award $0 +211K $0.00 211K Feb 27, 2022 Common Stock 211K $0.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock issued to the Reporting Person pursuant to an award of restricted stock units. The award vests in full on February 27, 2023, subject to the Reporting Person's continued service to the Issuer.
F2 50% of the shares of Common Stock subject to the stock option shall vest and become exercisable on February 27, 2023, and the remaining shares shall vest and become exercisable in equal installments on the last day of each of the following 12 months until fully vested on February 27, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.